These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 38233527)

  • 1. The dual function of cGAS-STING signaling axis in liver diseases.
    Li XJ; Qu JR; Zhang YH; Liu RP
    Acta Pharmacol Sin; 2024 Jun; 45(6):1115-1129. PubMed ID: 38233527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cGAS-STING Pathway: Novel Perspectives in Liver Diseases.
    Xu D; Tian Y; Xia Q; Ke B
    Front Immunol; 2021; 12():682736. PubMed ID: 33995425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactive modulators targeting STING adaptor in cGAS-STING pathway.
    Feng X; Liu D; Li Z; Bian J
    Drug Discov Today; 2020 Jan; 25(1):230-237. PubMed ID: 31758915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cGAS-STING signaling in cardiovascular diseases.
    Zhang Q; Shen L; Ruan H; Huang Z
    Front Immunol; 2024; 15():1402817. PubMed ID: 38803502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cGAS/STING Pathway: A Novel Target for Cancer Therapy.
    Gan Y; Li X; Han S; Liang Q; Ma X; Rong P; Wang W; Li W
    Front Immunol; 2021; 12():795401. PubMed ID: 35046953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cGAS-STING signaling pathway in gastrointestinal inflammatory disease and cancers.
    Ke X; Hu T; Jiang M
    FASEB J; 2022 Jan; 36(1):e22029. PubMed ID: 34907606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research progress of cGAS-STING signaling pathway in intestinal diseases.
    Wang J; Yao N; Chen Y; Li X; Jiang Z
    Int Immunopharmacol; 2024 Jun; 135():112271. PubMed ID: 38762923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonists and Inhibitors of the cGAS-STING Pathway.
    Yu X; Cai L; Yao J; Li C; Wang X
    Molecules; 2024 Jun; 29(13):. PubMed ID: 38999073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicinal chemistry perspective on cGAS-STING signaling pathway with small molecule inhibitors.
    Tian X; Xu F; Zhu Q; Feng Z; Dai W; Zhou Y; You QD; Xu X
    Eur J Med Chem; 2022 Dec; 244():114791. PubMed ID: 36206657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regulation of cGAS-STING signaling by RNA virus-derived components.
    Xie F; Zhu Q
    Virol J; 2024 May; 21(1):101. PubMed ID: 38693578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cGAS-STING signaling pathway in intestinal homeostasis and diseases.
    Yang Y; Wang L; Peugnet-González I; Parada-Venegas D; Dijkstra G; Faber KN
    Front Immunol; 2023; 14():1239142. PubMed ID: 37781354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cGAS-STING pathway: Post-translational modifications and functional implications in diseases.
    Liu J; Rui K; Peng N; Luo H; Zhu B; Zuo X; Lu L; Chen J; Tian J
    Cytokine Growth Factor Rev; 2022 Dec; 68():69-80. PubMed ID: 36151014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy.
    Oduro PK; Zheng X; Wei J; Yang Y; Wang Y; Zhang H; Liu E; Gao X; Du M; Wang Q
    Acta Pharm Sin B; 2022 Jan; 12(1):50-75. PubMed ID: 35127372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the cGAS-STING pathway in cancer development and oncotherapeutic approaches.
    Khoo LT; Chen LY
    EMBO Rep; 2018 Dec; 19(12):. PubMed ID: 30446584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDAC3 inhibition ameliorates ischemia/reperfusion-induced brain injury by regulating the microglial cGAS-STING pathway.
    Liao Y; Cheng J; Kong X; Li S; Li X; Zhang M; Zhang H; Yang T; Dong Y; Li J; Xu Y; Yuan Z
    Theranostics; 2020; 10(21):9644-9662. PubMed ID: 32863951
    [No Abstract]   [Full Text] [Related]  

  • 16. cGAS-STING signaling in cancer immunity and immunotherapy.
    Du H; Xu T; Cui M
    Biomed Pharmacother; 2021 Jan; 133():110972. PubMed ID: 33254021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cGAS-STING signalling in liver diseases.
    Chen R; Du J; Zhu H; Ling Q
    JHEP Rep; 2021 Oct; 3(5):100324. PubMed ID: 34381984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cGAS-STING pathway in pathogenesis and treatment of osteoarthritis and rheumatoid arthritis.
    Yang X; Zhao L; Pang Y
    Front Immunol; 2024; 15():1384372. PubMed ID: 38765007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between the SFTSV envelope glycoprotein Gn and STING inhibits the formation of the STING-TBK1 complex and suppresses the NF-κB signaling pathway.
    Jia Y; Li F; Liu Z; Liu S; Huang M; Gao X; Su X; Wang Z; Wang T
    J Virol; 2024 Mar; 98(3):e0181523. PubMed ID: 38421179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activation of cGAS/STING signaling pathway and its immunological role in the progression of nonalcoholic fatty liver disease].
    Sha CX; Ju LL; Zhou P; Yao DF; Yao M
    Zhonghua Gan Zang Bing Za Zhi; 2022 May; 30(5):564-568. PubMed ID: 35764553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.